Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Total Current Liabilities (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Total Current Liabilities for 5 consecutive years, with $36.1 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 138.13% to $36.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.1 million through Dec 2025, up 138.13% year-over-year, with the annual reading at $36.1 million for FY2025, 138.13% up from the prior year.
  • Total Current Liabilities for Q4 2025 was $36.1 million at Werewolf Therapeutics, up from $17.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $36.1 million in Q4 2025, with the low at $5.4 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $16.9 million, with a median of $15.1 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities soared 312.05% in 2022, then crashed 50.59% in 2023.
  • Over 5 years, Total Current Liabilities stood at $11.9 million in 2021, then soared by 102.03% to $24.0 million in 2022, then decreased by 19.22% to $19.4 million in 2023, then fell by 21.66% to $15.2 million in 2024, then surged by 138.13% to $36.1 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $36.1 million, $17.6 million, and $15.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.